Article Sidebar
Published:
Feb 3, 2017Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Green synthesis of CuO nanoparticles using Cassia auriculata leaf extract and in vitro evaluation of their biocompatibility with rheumatoid arthritis macrophages (RAW 264.7)
Abstract
Purpose: To undertake green synthesis of copper oxide nanoparticles (CuO NPs) using Cassia auriculata leaf extract and evaluate their biocompatibility with rheumatoid arthritis macrophages (RAW 264.7 cell line).
Methods: CuO NPs were prepared by heating a mixture of 10 mL of 0.01 M CuSO4 solution and 30 mL of C. auriculata extract at 80 °C for 1 h. The synthesized CuO NPs were characterized by x-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UVVis), energy-dispersive x-ray spectroscopy (EDS), scanning electron microscopy (SEM), transmission electron microscopy (TEM) and dynamic light scattering (DLS). The cytotoxicity of the NPs against RAW 264.7 cells was studied using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Results: The gradual change in color of the reaction solution from brownish yellow to dark brown indicated CuO NP formation. TEM images revealed spherical, polydispersed NPs (mean particle size, 23 nm). FTIR results indicated capping of polyphenols on the surface of the NPs. Most RAW 264.7 cells (> 95 %) remained alive following exposure to CuO NPs at concentrations of up to 200 μg/mL, indicating biocompatible with the cells.
Conclusion: An eco-friendly, low-cost, biosynthetic method for CuO NP preparation has been successfully developed using C. auriculata leaf extract. Furthermore, the nanoparticles are biocompatible with RAW 264.7 cell line.
Keywords: Cassia auriculata extract, Copper oxide nanoparticles, RAW 264.7 cell line, Rheumatoid arthritis
